• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嗜麦芽窄食单胞菌的抗生素敏感性概况。β-内酰胺/β-内酰胺酶抑制剂联合用药的体外活性。

Antibiotic susceptibility profile of Xanthomonas maltophilia. In vitro activity of beta-lactam/beta-lactamase inhibitor combinations.

作者信息

García-Rodríguez J A, García Sánchez J E, García García M I, García Sánchez E, Muñoz Bellido J L

机构信息

Department of Microbiology, Hospital Clínico Universitario, Salamanca, Spain.

出版信息

Diagn Microbiol Infect Dis. 1991 May-Jun;14(3):239-43. doi: 10.1016/0732-8893(91)90038-h.

DOI:10.1016/0732-8893(91)90038-h
PMID:1889176
Abstract

The susceptibility of 42 strains of Xanthomonas (Pseudomonas) maltophilia to 37 antibiotics (mainly beta-lactams, aminoglycosides, and fluorinated quinolones) was tested. Xanthomonas maltophilia was resistant to most beta-lactams, with ceftazidime, moxalactam, and ICI-194008 being the most active ones. Aminoglycosides had a very modest activity, with quinolones showing only moderate activity against this species. Trimethoprim/sufamethoxazole was effective against all strains tested. We also tested the synergy of several beta-lactam/beta-lactamase inhibitors against X. maltophilia. Only aztreonam/clavulanic acid at 3:1, 1:1 and, mainly, 2:1 combinations had synergistic activity, decreasing the rate of resistance from 92.8% for aztreonam alone to 32.4% for aztreonam-clavulanic acid at 1:1 and 0% for aztreonam-clavulanic acid at 2:1.

摘要

检测了42株嗜麦芽窄食单胞菌(假单胞菌属)对37种抗生素(主要是β-内酰胺类、氨基糖苷类和氟喹诺酮类)的敏感性。嗜麦芽窄食单胞菌对大多数β-内酰胺类耐药,头孢他啶、莫西沙星和ICI-194008是活性最强的。氨基糖苷类活性很弱,喹诺酮类对该菌仅表现出中等活性。甲氧苄啶/磺胺甲恶唑对所有测试菌株均有效。我们还测试了几种β-内酰胺类/β-内酰胺酶抑制剂对嗜麦芽窄食单胞菌的协同作用。只有氨曲南/克拉维酸在3:1、1:1以及主要是2:1的组合具有协同活性,将单独使用氨曲南时92.8%的耐药率降至氨曲南-克拉维酸1:1组合时的32.4%以及氨曲南-克拉维酸2:1组合时的0%。

相似文献

1
Antibiotic susceptibility profile of Xanthomonas maltophilia. In vitro activity of beta-lactam/beta-lactamase inhibitor combinations.嗜麦芽窄食单胞菌的抗生素敏感性概况。β-内酰胺/β-内酰胺酶抑制剂联合用药的体外活性。
Diagn Microbiol Infect Dis. 1991 May-Jun;14(3):239-43. doi: 10.1016/0732-8893(91)90038-h.
2
In vitro activities of beta-lactam-beta-lactamase inhibitor combinations against Stenotrophomonas maltophilia: correlation between methods for testing inhibitory activity, time-kill curves, and bactericidal activity.β-内酰胺-β-内酰胺酶抑制剂组合对嗜麦芽窄食单胞菌的体外活性:抑制活性检测方法、时间-杀菌曲线与杀菌活性之间的相关性
Antimicrob Agents Chemother. 1997 Dec;41(12):2612-5. doi: 10.1128/AAC.41.12.2612.
3
Kinetics of antimicrobial activity of aztreonam/clavulanic acid (2:1) against Xanthomonas maltophilia.
J Antimicrob Chemother. 1991 Apr;27(4):552-4. doi: 10.1093/jac/27.4.552.
4
In-vitro susceptibility of Xanthomonas maltophilia to aztreonam and clavulanic acid as a test for the presumptive identification of the species.
J Hosp Infect. 1991 Aug;18(4):324-5. doi: 10.1016/0195-6701(91)90192-b.
5
Susceptibility of 100 strains of Stenotrophomonas maltophilia to three beta-lactams and five beta-lactam-beta-lactamase inhibitor combinations.100株嗜麦芽窄食单胞菌对三种β-内酰胺类药物及五种β-内酰胺类-β-内酰胺酶抑制剂组合的敏感性
J Antimicrob Chemother. 1997 Nov;40(5):717-20. doi: 10.1093/jac/40.5.717.
6
Aztreonam-clavulanic acid synergy does not mean extended-spectrum beta-lactamase in Stenotrophomonas maltophilia.氨曲南-克拉维酸协同作用并不意味着嗜麦芽窄食单胞菌中存在超广谱β-内酰胺酶。
J Antimicrob Chemother. 1998 Apr;41(4):493-4. doi: 10.1093/jac/41.4.493.
7
Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model.嗜麦芽窄食单胞菌:治疗期间及体外药效学腔室模型中多重耐药菌株的出现
Antimicrob Agents Chemother. 1996 Dec;40(12):2859-64. doi: 10.1128/AAC.40.12.2859.
8
[Comparative activity of ticarcillin-clavulanic acid and various beta-lactams against Pseudomonas maltophilia].替卡西林-克拉维酸与多种β-内酰胺类药物对嗜麦芽窄食单胞菌的比较活性
Pathol Biol (Paris). 1987 Jun;35(5 Pt 2):805-8.
9
In vitro susceptibility of 124 Xanthomonas maltophilia (Stenotrophomonas maltophilia) isolates: comparison of the agar dilution method with the E-test and two agar diffusion methods.124株嗜麦芽窄食单胞菌(嗜麦芽寡养单胞菌)的体外药敏试验:琼脂稀释法与E试验及两种琼脂扩散法的比较
APMIS. 1996 Feb;104(2):108-14.
10
Activity of beta-lactamase inhibitors in combination with new beta-lactam antibiotics against resistant gram-negative organisms.β-内酰胺酶抑制剂与新型β-内酰胺类抗生素联合应用对耐药革兰氏阴性菌的活性。
Diagn Microbiol Infect Dis. 1984 Jun;2(3):255-60. doi: 10.1016/0732-8893(84)90039-7.

引用本文的文献

1
Global mapping of antibiotic resistance rates among clinical isolates of Stenotrophomonas maltophilia: a systematic review and meta-analysis.全球临床分离嗜麦芽寡养单胞菌耐药率的地图绘制:系统评价和荟萃分析。
Ann Clin Microbiol Antimicrob. 2024 Mar 19;23(1):26. doi: 10.1186/s12941-024-00685-4.
2
Global prevalence and antibiotic resistance in clinical isolates of : a systematic review and meta-analysis.全球临床分离株中的患病率及抗生素耐药性:一项系统评价和荟萃分析。
Front Med (Lausanne). 2023 May 5;10:1163439. doi: 10.3389/fmed.2023.1163439. eCollection 2023.
3
Activity of Aztreonam in Combination with Avibactam, Clavulanate, Relebactam, and Vaborbactam against Multidrug-Resistant Stenotrophomonas maltophilia.
头孢他啶阿维巴坦、克拉维酸、雷利巴坦和沃博巴坦对多重耐药嗜麦芽窄食单胞菌的活性。
Antimicrob Agents Chemother. 2020 Nov 17;64(12). doi: 10.1128/AAC.00297-20.
4
Cross-Canada survey of resistance of 2747 aerobic blood culture isolates to piperacillin/tazobactam and other antibiotics.对2747株需氧血培养分离株对哌拉西林/他唑巴坦及其他抗生素耐药性的全加拿大调查。
Can J Infect Dis. 1998 Jan;9(1):33-44. doi: 10.1155/1998/730838.
5
Stenotrophomonas maltophilia: Significant contemporary hospital pathogen - review.嗜麦芽寡养单胞菌:重要的当代医院病原体——综述。
Folia Microbiol (Praha). 2010 May;55(3):286-94. doi: 10.1007/s12223-010-0043-4. Epub 2010 Jun 6.
6
Antimicrobial therapy for Stenotrophomonas maltophilia infections.嗜麦芽窄食单胞菌感染的抗菌治疗。
Eur J Clin Microbiol Infect Dis. 2007 Apr;26(4):229-37. doi: 10.1007/s10096-007-0279-3.
7
Occurrence of variants with temperature-dependent susceptibility (TDS) to antibiotics among Stenotrophomonas maltophilia clinical strains.嗜麦芽窄食单胞菌临床菌株中存在对抗生素具有温度依赖性敏感性(TDS)的变体。
Folia Microbiol (Praha). 2001;46(2):151-5. doi: 10.1007/BF02873595.
8
Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia.嗜麦芽窄食单胞菌相关感染的微生物学及临床方面
Clin Microbiol Rev. 1998 Jan;11(1):57-80. doi: 10.1128/CMR.11.1.57.
9
In vitro activities of beta-lactam-beta-lactamase inhibitor combinations against Stenotrophomonas maltophilia: correlation between methods for testing inhibitory activity, time-kill curves, and bactericidal activity.β-内酰胺-β-内酰胺酶抑制剂组合对嗜麦芽窄食单胞菌的体外活性:抑制活性检测方法、时间-杀菌曲线与杀菌活性之间的相关性
Antimicrob Agents Chemother. 1997 Dec;41(12):2612-5. doi: 10.1128/AAC.41.12.2612.
10
Activity of trimethoprim/sulfamethoxazole plus polymyxin B against multiresistant Stenotrophomonas maltophilia.甲氧苄啶/磺胺甲恶唑联合多粘菌素B对多重耐药嗜麦芽窄食单胞菌的活性。
Eur J Clin Microbiol Infect Dis. 1996 Nov;15(11):879-82. doi: 10.1007/BF01691222.